SupplementDrug
Lacticaseibacillus casei clinical trials
Also written Lactobacillus casei.
Counted the way a researcher would: Lacticaseibacillus casei with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
Keep track of what changes. Save the Lacticaseibacillus casei studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 4
Bio-K Plus International Inc. (2) · Hospital Cristo Re (1) · Georgetown University (1) · National Institute of Pediatrics, Mexico (1) · University of Minnesota (1)
Often tested with
Tested in the same studies.
Lactobacillus acidophilus CL1285 (2) · Mesalamine (1) · Lactobacillus rhamnosus (1) · Bifidobacterium bifidum (1)
Studies
Open first, then newest update. How each study uses Lacticaseibacillus casei is read from its arms, and is right about nine times in ten.
Testing it · 6
- Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle SorenessRecruitingNot applicableUniversity of MinnesotaNCT07219498Written as Lactobacillus casei
- Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with LeukemiaEnrolling by invitationPhase 2National Institute of Pediatrics, MexicoNCT06560879Written as Lactobacillus casei
- BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile InfectionSuspendedPhase 3Bio-K Plus International Inc.NCT01202630Written as Lactobacillus acidophilus CL1285® and Lactobacillus casei
- Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult PatientsCompletedPhase 3Bio-K Plus International Inc.NCT00328263Written as Lactobacillus acidophilus CL1285 and Lactobacillus casei
- Mesalazine and/or Lactobacillus Casei in the Diverticular Disease of the ColonCompletedPhase 4Hospital Cristo ReNCT01534754Written as Mesalazine plus Lactobacillus casei
- Decreasing Rates of Illness in Kids (DRINK)CompletedPhase 3Georgetown UniversityNCT00356382Written as Lactobacillus (L.) casei
Codes
What other systems call Lacticaseibacillus casei · ClinicalTrials.gg INT017888
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 1592255 | — | One source FDA |
| Wikidata | Q139777 | Lacticaseibacillus casei | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.